To drive innovative solutions and accelerate drug development

To offer clients comprehensive services tailored to their scientific needs

To strengthen global competitiveness in preclinical R&D

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127719655/en/

Dev4All and Pharmaseed Join Forces in Commercial Cooperation (Graphic: Business Wire)

Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract Research Organization (CRO) with over 20 years of expertise in preclinical drug development.

This partnership combines the strengths of both organizations to offer an integrated, end-to-end approach for preclinical development. Together, Dev4All and Pharmaseed aim to deliver comprehensive and competitive solutions that accelerate drug development and address the complexities of today’s R&D landscape.

With over two decades of experience in CRO services and ten years advancing drug development candidates from TRL3 to TRL5, this close cooperation provides tailored preclinical support, cutting-edge laboratory capabilities, and strategic expertise, complementing clients’ R&D efforts worldwide.

Revital Rattenbach, Executive Chair of Dev4All, said: "I am thrilled about the new collaboration between Dev4All and Pharmaseed, which marks an exciting step forward in our shared commitment to innovation. This commercial cooperation empowers us to scale our capabilities, elevate our global impact, and deliver tailor-made solutions that meet our client's needs while maintaining the highest standards of scientific rigor."

Shmuel Landau, Co-CEO of Pharmaseed, said: "This collaboration with Dev4All is an excellent opportunity to expand our European presence and integrate our comprehensive preclinical solutions with DEV4ALL innovative R&D platform. Together, we are committed to deliver top-tier services, ensuring clients achieve their scientific and clinical milestones."

About Dev4All:
Dev4All, powered by 4P-Pharma, is an R&D booster designed to provide a wide range of preclinical solutions. With a decade-long foundation in preclinical research, Dev4All is committed to transforming innovative ideas into clinical-stage candidates through collaboration and scientific excellence.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241127719655/en/

Dev4All
Martina Gil - martinagil@dev4allsas.com
Daniel Sanchez Lopez - danielsanchezlopez@dev4allsas.com

Logo

Images

Tags

More Like This

4P-Pharma Announces Total Capital of €15 Million Successfully Secured in Second Closing

Recipharm and PLG announce strategic partnership to accelerate development projects

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development

LABCONNECT ACQUIRES SCIENTIFIC CONSULTANCY A4P

Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform'

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs